{"id":"ser120-nasal-spray-750-ng-day","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by activating the 5-HT1A receptor, which is involved in regulating mood and anxiety. This leads to an increase in the levels of certain neurotransmitters, such as serotonin and dopamine, which can help alleviate symptoms of depression and anxiety.","oneSentence":"SER120 is a serotonin receptor agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:05.210Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"}]},"trialDetails":[{"nctId":"NCT01259128","phase":"PHASE3","title":"Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia","status":"COMPLETED","sponsor":"Serenity Pharmaceuticals, Inc.","startDate":"2010-04","conditions":"Nocturia","enrollment":32},{"nctId":"NCT01357356","phase":"PHASE2, PHASE3","title":"Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia","status":"COMPLETED","sponsor":"Serenity Pharmaceuticals, Inc.","startDate":"2011-05","conditions":"Nocturia","enrollment":750}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SER120 nasal spray 750 ng/day","genericName":"SER120 nasal spray 750 ng/day","companyName":"Serenity Pharmaceuticals, Inc.","companyId":"serenity-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SER120 is a serotonin receptor agonist. Used for Major depressive disorder, Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}